Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

6-APB

C11H13NO CAS 286834-85-3 Analytical reference material — not for human consumption
Preferred name
6-APB
IUPAC name
1-(1-benzofuran-6-yl)propan-2-amine
Parent CAS number (reference)
286834-85-3
Molecular formula
C11H13NO
Molecular weight
175.23 g/mol
InChIKey
FQDAMYLMQQKPRX-UHFFFAOYSA-N
PubChem
CID 9794343
Source
PubChem
Verified synonyms & catalog abbreviations
6-(2-Aminopropyl)benzofuran Benzofury 6APB 6 APB

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

6-APB (Benzofury)

Entactogen / psychedelic (monoamine releaser and 5-HT2B agonist) 6-Substituted benzofuran (primary amine)
Verified PubChem & CAS Identity C11H13NO · CAS 286834-85-3 · CID 9794343
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 175.23 g/mol
Peer-Reviewed & Agency Citations 3 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

6-APB is a 6-benzofuran amphetamine analogue and a monoamine releaser with a more psychedelic edge than MDMA or 5-MAPB. It is also an agonist at 5-HT2B. That receptor is the valvular-heart concern shared with fenfluramine and other chronic 5-HT2B agonists, so frequent repeated use is a different risk from a single spaced exposure. The primary amine lasts longer than N-methyl 5-MAPB.

Biotransformation & Active Metabolites

Not a prodrug of MDA. Succinate is a common salt and is heavier than the freebase (C11H13NO, 175.23 g/mol) or the hydrochloride. PsychonautWiki oral bands should not be copied blindly from one salt onto another. 6-MAPB is the N-methyl analogue and has its own, lower TripSit oral band.

Temporal Pharmacokinetics

Long entactogen with a psychedelic tint, more stimulation early and a heavy, warm body later. Less 'clean' than 5-MAPB and much longer.

  1. Onset 30–60 minutes
  2. Peak Window 3–4 hours
  3. Total Window 7–10 hours
  4. Residual / Half-Life After-effects 6–48 hours. PsychonautWiki lists tolerance returning toward baseline only after several weeks for this compound.

Threshold 15 mg, light 30–60 mg, common 60–90 mg, strong 90–120 mg, heavy above 120 mg. Come-up is 60–120 minutes. That slow rise is the entire redose problem: a second dose at one hour arrives during a 3–4 hour peak and a 7–10 hour total course.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
15 mg
Cognitive & Sensory

A mild mood and body shift.

Somatic & Autonomic

Little more than a warm flush.

Light
30–60 mg
Cognitive & Sensory

Soft empathy, light visuals, and stimulation that has not peaked.

Somatic & Autonomic

Nausea, jaw tension, and a rising heart rate.

Common Reference
60–90 mg
Cognitive & Sensory

Full entactogenic and mildly psychedelic effects, music enhancement, and emotional openness over many hours.

Somatic & Autonomic

Bruxism, sweating, dilated pupils, vasoconstriction, and a sustained cardiovascular load.

Strong
90–120 mg
Cognitive & Sensory

Intense visuals for a benzofuran, overwhelming empathy or anxiety, and a very long course.

Somatic & Autonomic

Hyperthermia risk, vomiting, and marked blood-pressure elevation.

Heavy / Toxic Zone
120 mg+
Cognitive & Sensory

A toxic, confused entactogenic state. More material does not fix a come-up that was simply slow.

Somatic & Autonomic

Severe hyperthermia, serotonin toxicity if combined with another releaser, and seizures with tramadol.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

MDMA, 5-MAPB, 4-FA, MDA, and other serotonin releasers

A second releaser on top of a 7–10 hour serotonin releaser is a hyperthermia and serotonin-toxicity combination.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Elevated Hazard — Avoid

Stimulants, 25x-NBOMe, and hot crowded settings

6-APB already lasts most of a day. Added stimulants, NBOMes, and heat raise hyperthermia, vasoconstriction, and seizure risk.

Alcohol

Worsens dehydration and judgment across a very long course.

Caution / Receptor Attenuation

SSRIs

Blunt the entactogenic phase unevenly. Not a safety factor.

Frequent repeated use via 5-HT2B

Chronic 5-HT2B agonism is the valvular-heart concern. Spacing is part of the risk profile, not only the comedown.

Structural Isomer & Sibling Comparison

6-APB is the long primary-amine benzofuran: common 60–90 mg, come-up 1–2 hours, total 7–10 hours, more psychedelic than 5-MAPB. 5-MAPB common is 60–80 mg over 5–8 hours and warmer. 6-MAPB, the N-methyl sibling, is placed by TripSit at a common oral 40–80 mg and is generally described as smoother and less stimulating. All three forbid stacked releasers. Salt mass (succinate versus hydrochloride) moves the real amount inside every one of these bands.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

PsychonautWiki lists full tolerance with repeated use, a half-reduction on the order of 3–4 weeks, and a return toward baseline around 6–8 weeks, with cross-tolerance to dopaminergic stimulants and, in practice, to other entactogens. That is a longer reset than a weekend stimulant. The crash is serotonergic. Urge to redose during the slow come-up is behavioral, and it is how heavy amounts happen.

Comprehensive Analytical & Toxicological Monograph

6-APB (1-(1-benzofuran-6-yl)propan-2-amine; benzofury; CAS 286834-85-3, PubChem CID 9794343) is the 6-substituted benzofuran primary amine supplied as pure powder or crystals (freebase parent C11H13NO, 175.23 g/mol). It is a monoamine releaser with a psychedelic edge and 5-HT2B agonist activity, the receptor relevant to valvular risk when use is frequent. PsychonautWiki oral bands are threshold 15 mg, light 30–60 mg, common 60–90 mg, strong 90–120 mg, and heavy above 120 mg. Onset is 30–60 minutes, come-up 60–120 minutes, and the total course is 7–10 hours, so a redose at one hour stacks onto the peak. Succinate and hydrochloride do not weigh the same per active molecule. It is longer and more psychedelic than 5-MAPB. Do not combine with MAOIs, MDMA, other releasers, or tramadol.

Chemical Architecture & Structural Profile

6-APB (1-(1-benzofuran-6-yl)propan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C11H13NO and a molar mass of 175.23 g/mol. The parent molecule is indexed under CAS registry number 286834-85-3 and in the NCBI PubChem database as CID 9794343 (Standard InChIKey: FQDAMYLMQQKPRX-UHFFFAOYSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 6-APB is indexed within the Substituted amphetamines, Substituted benzofurans structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)